21. Complete response of advanced cutaneous squamous cell and basal cell carcinomas with sequential cemiplimab and sonidegib therapy. (2nd December 2021) Authors: Weis, J.; Grote, C.; Weichenthal, M.; Hauschild, A. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 36:Number 1(2022)Supplement Page Start: 66 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
22. Differential Code Bias Estimation using Multi‐GNSS Observations and Global Ionosphere Maps. Issue 3 (11th September 2014) Authors: Montenbruck, O.; Hauschild, A.; Steigenberger, P. Journal: Navigation Issue: Volume 61:Issue 3(2014) Page Start: 191 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
23. Effectiveness, safety and utilization of vismodegib in locally advanced basal cell carcinoma under real‐world conditions in Germany – The non‐interventional study NIELS. (27th May 2021) Authors: Gutzmer, R.; Schulze, H.‐J.; Hauschild, A.; Leiter, U.; Meier, F.; Haferkamp, S.; Ulrich, C.; Wahl, R.U.; Berking, C.; Herbst, R.; Häckl, M.; Schadendorf, D. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 35:Number 8(2021) Page Start: 1678 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
24. Flight results of GPS‐based attitude determination for the Canadian CASSIOPE satellite. Issue 1 (17th January 2020) Authors: Hauschild, A.; Montenbruck, O.; Langley, R. B. Journal: Navigation Issue: Volume 67:Issue 1(2020) Page Start: 83 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
25. Intermittent BRAF‐inhibitor therapy is a feasible option: report of a patient with metastatic melanoma. (1st January 2014) Authors: Koop, A.; Satzger, I.; Alter, M.; Kapp, A.; Hauschild, A.; Gutzmer, R. Journal: British journal of dermatology Issue: Volume 170:Number 1(2014:Jan.) Page Start: 220 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
26. Intermittent BRAF‐inhibitor therapy is a feasible option: report of a patient with metastatic melanoma. (January 2014) Authors: Koop, A.; Satzger, I.; Alter, M.; Kapp, A.; Hauschild, A.; Gutzmer, R. Journal: British journal of dermatology Issue: Volume 170:Number 1(2014:Jan.) Page Start: 220 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
27. More than 5000 patients with metastatic melanoma in Europe per year do not have access to recommended first-line innovative treatments. (April 2017) Authors: Kandolf Sekulovic, L.; Peris, K.; Hauschild, A.; Stratigos, A.; Grob, J.-J.; Nathan, P.; Dummer, R.; Forsea, A.-M.; Hoeller, C.; Gogas, H.; Demidov, L.; Lebbe, C.; Blank, C.; Olah, J.; Bastholt, L.; Herceg, D.; Neyns, B.; Vieira, R.; Hansson, J.; Rutkowski, P. Journal: European journal of cancer Issue: Volume 75(2017) Page Start: 313 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
28. Orbit and Clock Determination of QZS‐1 Based on the CONGO Network. Issue 1 (20th March 2013) Authors: Steigenberger, P.; Hauschild, A.; Montenbruck, O.; Rodriguez‐Solano, C.; Hugentobler, U. Journal: Navigation Issue: Volume 60:Issue 1(2013) Page Start: 31 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
29. Photodynamic therapy simplified: nonprepared, moderate‐grade actinic keratosis lesions respond equally well to 5‐aminolaevulinic acid patch photodynamic therapy as do mild lesions. (1st November 2015) Authors: Szeimies, R.M.; Hauschild, A.; Ortland, C.; Moor, A.C.E.; Stocker, M.; Surber, C. Journal: British journal of dermatology Issue: Volume 173:Number 5(2015:Nov.) Page Start: 1277 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
30. Photodynamic therapy simplified: nonprepared, moderate‐grade actinic keratosis lesions respond equally well to 5‐aminolaevulinic acid patch photodynamic therapy as do mild lesions. (26th August 2015) Authors: Szeimies, R.M.; Hauschild, A.; Ortland, C.; Moor, A.C.E.; Stocker, M.; Surber, C. Journal: British journal of dermatology Issue: Volume 173:Number 5(2015:Nov.) Page Start: 1277 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗